Ninety One UK Ltd Has $169.08 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)
Ninety One UK Ltd trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 51.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 335,354 shares of the healthcare conglomerate’s stock after selling 357,503 shares during the quarter. Ninety One UK Ltd’s holdings in UnitedHealth Group were worth $169,082,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Cascade Investment Advisors Inc. bought a new position in shares of UnitedHealth Group in the first quarter valued at $28,000. Strategic Investment Solutions Inc. IL bought a new position in shares of UnitedHealth Group during the first quarter valued at about $35,000. WFA of San Diego LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at about $39,000. Grayhawk Investment Strategies Inc. lifted its position in shares of UnitedHealth Group by 168.6% during the first quarter. Grayhawk Investment Strategies Inc. now owns 94 shares of the healthcare conglomerate’s stock valued at $60,000 after purchasing an additional 59 shares in the last quarter. Finally, Power Corp of Canada bought a new position in shares of UnitedHealth Group during the first quarter valued at about $48,000. 85.69% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Trading Down 0.6 %
Shares of UnitedHealth Group stock opened at $531.12 on Friday. The firm has a market cap of $491.24 billion, a PE ratio of 23.05, a PEG ratio of 1.67 and a beta of 0.61. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.80 and a quick ratio of 0.80. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $554.70. The company has a 50 day simple moving average of $537.38 and a two-hundred day simple moving average of $506.53.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share for the quarter, topping analysts’ consensus estimates of $6.33 by $0.23. The firm had revenue of $92.36 billion during the quarter, compared to analyst estimates of $91.41 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.58%. The business’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period in the previous year, the business posted $5.79 EPS. Analysts expect that UnitedHealth Group Incorporated will post 24.95 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, December 4th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, December 1st. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is 32.64%.
Analysts Set New Price Targets
Several analysts have commented on the stock. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a research report on Monday, October 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, November 21st. UBS Group raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $520.00 to $640.00 in a research report on Monday, October 16th. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. Finally, StockNews.com downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $578.05.
View Our Latest Stock Analysis on UnitedHealth Group
Insider Activity at UnitedHealth Group
In related news, Director Stephen J. Hemsley sold 121,515 shares of the company’s stock in a transaction on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the completion of the sale, the director now directly owns 521,818 shares in the company, valued at approximately $282,084,374.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the business’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Stephen J. Hemsley sold 121,515 shares of the business’s stock in a transaction on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the transaction, the director now directly owns 521,818 shares in the company, valued at $282,084,374.44. The disclosure for this sale can be found here. Insiders sold 192,094 shares of company stock worth $104,507,072 in the last three months. 0.35% of the stock is owned by insiders.
UnitedHealth Group Company Profile (Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
NYSE: UNH” width=”650″ height=”350″ loading=”lazy”>
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and UnitedHealth Group wasn’t on the list.
While UnitedHealth Group currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.